144 related articles for article (PubMed ID: 38347094)
21. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS; Fakih M; Ali SM; Elvin JA; Schrock AB; Suh J; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Sun J; Miller VA; Stephens PJ; Gay LM
Cancer; 2018 Apr; 124(7):1358-1373. PubMed ID: 29338072
[TBL] [Abstract][Full Text] [Related]
22. Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases.
Bergen ES; Scherleitner P; Ferreira P; Kiesel B; Müller C; Widhalm G; Dieckmann K; Prager G; Preusser M; Berghoff AS
ESMO Open; 2021 Jun; 6(3):100168. PubMed ID: 34098230
[TBL] [Abstract][Full Text] [Related]
23. Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.
Duchnowska R; Sperinde J; Chenna A; Huang W; Weidler JM; Winslow J; Haddad M; Paquet A; Lie Y; Trojanowski T; Mandat T; Kowalczyk A; Czartoryska-Arłukowicz B; Radecka B; Jarosz B; Staszkiewicz R; Kalinka-Warzocha E; Chudzik M; Biernat W; Jassem J
Neuro Oncol; 2015 Sep; 17(9):1241-9. PubMed ID: 25681308
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer.
Yue M; Wu S; Liu C; Cai L; Wang X; Jia Y; Han D; Liu Y
Breast Cancer Res Treat; 2024 Jan; 203(2):373-381. PubMed ID: 37843776
[TBL] [Abstract][Full Text] [Related]
25. Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.
Melisko ME; Moore DH; Sneed PK; De Franco J; Rugo HS
J Neurooncol; 2008 Jul; 88(3):359-65. PubMed ID: 18398574
[TBL] [Abstract][Full Text] [Related]
26. Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.
Prete AA; Manca P; Messina M; Formica V; Frassineti GL; Zampino MG; Corsi DC; Orciuolo C; Prisciandaro M; Bergamo F; Angerilli V; Scartozzi M; Casagrande M; Masi G; Ronzoni M; Morano F; Vettore V; Salmaso R; Rasola C; Maddalena G; Del Bianco P; Milione M; Cremolini C; Fassan M; Pietrantonio F; Lonardi S
Eur J Cancer; 2023 Mar; 182():87-97. PubMed ID: 36753836
[TBL] [Abstract][Full Text] [Related]
27. CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary.
Bachmann C; Grischke EM; Fehm T; Staebler A; Schittenhelm J; Wallwiener D
J Cancer Res Clin Oncol; 2013 Apr; 139(4):551-6. PubMed ID: 23224376
[TBL] [Abstract][Full Text] [Related]
28. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
29. Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular Features.
Desette A; Guichet PO; Emambux S; Masliantsev K; Cortes U; Ndiaye B; Milin S; George S; Faigner M; Tisserand J; Gaillard A; Brot S; Wager M; Tougeron D; Karayan-Tapon L
Cell Mol Gastroenterol Hepatol; 2023; 16(5):757-782. PubMed ID: 37482243
[TBL] [Abstract][Full Text] [Related]
30. Brain metastases in colorectal cancer: prognostic factors and survival analysis.
Del Carpio Huerta L; Virgili Manrique AC; Szafranska J; Martin-Richard M; Paez Lopez-Bravo D; Sebio Garcia A; Espinosa Mariscal I; Gomila Pons P; Andres Granyo M; Barba Joaquin A; Barnadas Molins A; Tobeña Puyal M
Int J Colorectal Dis; 2018 Nov; 33(11):1517-1523. PubMed ID: 29943356
[TBL] [Abstract][Full Text] [Related]
31. Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits.
Wang H; Liu Q; Zhang M; Zhang J; Ran R; Ma Y; Yang J; Wang F; He S; Zhao X; Wang L; Zhang L; Dong D; Yang J
Front Oncol; 2023; 13():1105474. PubMed ID: 37397372
[TBL] [Abstract][Full Text] [Related]
32. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.
Luen SJ; Salgado R; Fox S; Savas P; Eng-Wong J; Clark E; Kiermaier A; Swain SM; Baselga J; Michiels S; Loi S
Lancet Oncol; 2017 Jan; 18(1):52-62. PubMed ID: 27964843
[TBL] [Abstract][Full Text] [Related]
33. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
Sauvageot S; Mollevi C; Thomas QD; Charissoux M; Darlix A; Rigau V; Bauchet L; Quantin X; Pujol JL; Roch B; Boetto J
J Neurosurg; 2024 Jan; ():1-11. PubMed ID: 38241682
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 Overexpression on Tumor-Infiltrating Lymphocytes Related to Better Prognosis of Colorectal Cancer.
Wang JL; Yu T; Sun TT; Feng Y; Xiong H; Fang JY
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337839
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
[TBL] [Abstract][Full Text] [Related]
38. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study.
Internò V; Massari F; Rudà R; Maiorano BA; Caffo O; Procopio G; Bracarda S; Atzori F; Passarelli A; Bersanelli M; Stellato M; Fornarini G; Galli L; Ortega C; Zanardi E; Incorvaia L; Facchini G; Giron Berrios JR; Ricotta R; Santoni M; Funaioli C; Trerotoli P; Porta C; Rizzo M
ESMO Open; 2023 Aug; 8(4):101598. PubMed ID: 37467658
[TBL] [Abstract][Full Text] [Related]
39. Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
Zhu Y; Liu C; Xu Z; Zou Z; Xie T; Xing P; Wang L; Li J
Chin Med J (Engl); 2023 Nov; 136(21):2551-2561. PubMed ID: 37160733
[TBL] [Abstract][Full Text] [Related]
40. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
